In the context of cancer, siRNA can be designed to target and silence oncogenes, which are genes that promote cancer cell growth and survival. By inhibiting these genes, siRNA can reduce tumor growth and even induce apoptosis (programmed cell death) in cancer cells. This makes siRNA a promising tool for cancer therapy, particularly for cancers that are resistant to traditional treatments.
